IDEAYA Biosciences
Stu Dorman currently serves as the Chief Commercial Officer at IDEAYA Biosciences. Previously, Dorman was the Vice President and Oncology Business Unit Head at Gilead Sciences, where responsibilities included overseeing strategic initiatives within the oncology segment. Prior experience includes a role as Senior Consultant/Manager at Trinity Partners, LLC, contributing expertise in commercial strategy and market analysis.
This person is not in any teams
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California